WuXi AppTec (OTCMKTS:WUXAY) Hits New 1-Year High – Still a Buy?

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY)’s stock price reached a new 52-week high on Tuesday . The company traded as high as $27.08 and last traded at $27.08, with a volume of 121 shares changing hands. The stock had previously closed at $25.41.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of WuXi AppTec from a “hold” rating to a “strong-buy” rating in a research report on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. According to MarketBeat.com, WuXi AppTec has a consensus rating of “Strong Buy”.

WuXi AppTec Price Performance

The business has a 50-day moving average of $23.92 and a 200 day moving average of $19.04.

About WuXi AppTec

WuXi AppTec is a global pharmaceutical and biotechnology services company that provides research, development, and manufacturing support to pharmaceutical, biotechnology, and medical device companies. Its integrated platform is designed to help customers discover, develop, test, and manufacture medicines and healthcare products.

The company’s services include small-molecule drug discovery and development, laboratory testing, clinical research support, and pharmaceutical manufacturing. WuXi AppTec also provides capabilities in biologics, cell and gene therapies, medical devices, and other advanced therapeutic areas, serving customers across multiple stages of the product-development process.

Founded in 2000, WuXi AppTec is headquartered in Shanghai, China, and operates through a global network of research, testing, and manufacturing facilities in China, the United States, Europe, and other international markets.